Resources

Your selections:

Clear all

Show Filters

We found 241 resources that match your search.

Rifampin

Document Date:

Rifampin Capsules, Package Insert

Rifampin is indicated in the treatment of all forms of tuberculosis.

Document Date:

Rifapentine

Document Date:

Rifapentine (Priftin)

The following side effects have been associated with the use of rifapentine:

Document Date:

Rilpivirine (Edurant)

The following serious side effects have been associated with the use of rilpivirine: Depression or mood changes. Be sure to contact your health care provider immediately if you are feeling sad or hopeless, feeling anxious or restless, or have thoughts of hurting yourself (suicide) or have tried to…

Document Date:

Rilpivirine (TMC278, Edurant) Investigator Brochure

Document Date:

Ritonavir (Norvir) Tablets/Oral Solution, Package Insert

NORVIR is an HIV protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.

Document Date:

RSV 276

Document Date:

RSV 6120/DeltaNS2/1030s

Document Date:

RSV D46/NS2/N/deltaM2-2-HindIII

Document Date:

RSV DeltaNS2-Delta1313-I1314L

Document Date:

rVSV HIV Vaccines

Document Date:

Safety Workshop October 2016

.zip file contains: Case review on adverse events Safety training presentations on adverse events, expedited reporting and assessment, Expedited reporting via DAERS a safety training case study handout Training given in the Republic of South Africa in October 2016.

Document Date:

SAR441236

Document Date:

Selzentry (maraviroc) Tablets and Oral Solution, Package Insert

SELZENTRY is a CCR5 co-receptor antagonist indicated in combination with other antiretroviral agents for the treatment of only CCR5-tropic HIV-1 infection in patients 2 years of age and older weighing at least 10 kg.

Document Date:

Semaglutide (Ozempic) Package Insert

Document Date:

Signature Requirement Guidance

Document Date:

Sofosbuvir/Velapatasvir (Epclusa)

Document Date:

Study Physician Attestation and Agreement for Electronic Signatures

This form is to document that the signator of this document is authorized to use the DAIDS-ES system, and understands that their electronic signature (eSignature) is used to electronically sign database records.

Document Date:

Study Statuses

Study statuses and milestones handout.

Document Date:

Tamoxifen Citrate Package Insert

Tamoxifen Citrate Tablets USP, a nonsteroidal antiestrogen, are for oral administration.

Document Date:

Tenofovir Alafenamide/Elvitegravir

Document Date:

Tenofovir Disoproxil Fumarate (Viread) Package Insert

VIREAD is a nucleotide analog HIV-1 reverse transcriptase inhibitor and an HBV reverse transcriptase inhibitor. VIREAD is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older. (1) VIREAD is indicated…

Document Date:

Tenofovir Disoproxil Fumarate (Viread) Risk List

The following side effects have been associated with the use of tenofovir:

Document Date:

Tenofovir Gel

Document Date: